Drug Research
Sartorius and HOF Sonderanlagenbau Partnership Creates Streamlined Offering of Freeze-Thaw Solutions for Biological Products
Sartorius and HOF Sonderanlagenbau, announced a partnership today to integrate two HOF horizontal plate freeze-thaw units into Sartorius’ portfolio offering customers a full suite of compatible freeze-thaw equipment and consumables. This partnership will enable faster and easier implementation of...
Articles
Why there is no “one-size-fits-all” approach to bioavailability
In this article, Dr. Robert Lee, president, Lubrizol Life Science Health (LLS Health) – CDMO Division, explores why every drug development project is unique when it comes to enhancing bioavailability and discusses how companies can overcome bioavailability challenges and...
Drug Research
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from MFDS
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization for Spikevax®, Moderna's COVID-19 vaccine (mRNA-1273) manufactured by Samsung Biologics, a...
Drug Research
Recent Trends & Opportunities in Digital Therapeutics Industry: The Future of Healthcare
Digital therapeutics is a branch of digital health that is the amalgamation of innovative technologies, services, and products for healthcare and wellness. Digital therapeutics are used independently or in the combination with medical devices, therapies medications are optimized according...
Drug Research
FDA clears AstraZeneca’s Covid antibody treatment for immunocompromised
The FDA authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus.
The FDA issued an emergency use authorization Wednesday for AstraZeneca’s antibody cocktail,...
Drug Research
Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders
Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for metabolic disorders.
Under the terms of the agreement, Lilly will have a license to...
Drug Research
Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19
Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This decision comes just hours...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.